235 Studies Now Enrolling
Menu
Search
Medical Condition
- Show all (41)
- Autoimmune Disorders (1)
- Bone & Muscle (2)
- COVID-19 (Coronavirus) (1)
- Ear, Nose and Throat (8)
- Endocrine & Metabolic Disease (1)
- (-) Eye (2)
- Healthy Volunteers (8)
- Kidney Disease (1)
- Neurological Disorders (12)
- Obesity (2)
- Obstetrics & Gynecology (1)
- (-) Pediatrics (1)
- Psychiatric Disorders (1)
Displaying 1 - 3 of 3
Condition: Pediatrics
Investigator: Lawrence Lustig, MD
Status: Currently Recruiting
The CHORD clinical trial, sponsored by Decibel Therapeutics, is looking at the use of the gene therapy DB-OTO for children born with hearing loss related to changes in the OTOF gene. The goal of this trial is to assess different doses of DB-OTO to find out if it is safe, well-tolerated, and its…
Research Study of New Treatment Called NT-501 (Encapsulated Cell Therapy (ECT) Implant) for Glaucoma
Condition: Eye / Glaucoma
Investigator: George Cioffi, MD
Status: Closed
Glaucoma is a given name of a group of diseases that affect the retinal ganglion cells in the eye and the optic nerve. Glaucoma cause degeneration of the retinal ganglion cells in the retina and their projections (axons) that form the optic nerve. Retinal ganglion cells and their axons transmit all of our vision information from the eye to the brain through…
Condition: Eye
Investigator: Stephen Tsang, MD, PhD
Status: Closed
Stargardt macular degeneration isa genetic condition, which in mostcases causes vision loss early in lifeand leads to legal blindness. Thereis currently no FDA-approvedtreatment.This trial will evaluate the safetyand effects of ALK-001, a newpotential drug treatment, on theprogression of…